Teyi Pharmaceutical Group Co.,Ltd engages in the research and development, production, and sale of Chinese patented medicines, pharmaceutical preparations, raw materials, and products in the People's Republic of China. The company's products are used in respiratory system, cardiovascular and cerebrovascular, respiratory, cardiovascular, and digestive systems. The company was formerly known as Guangdong Taicheng Pharmaceutical Co., Ltd. and changed its name to Teyi Pharmaceutical Group Co.,Ltd in November 2016. The company was founded in 2002 and is based in Taishan, the People's Republic of China.
Research context
Teyi Pharmaceutical Group Co.,Ltd appears in PyInvesting’s Shenzhen Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- CNY
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
5 years, 6 months ago
Teyi Pharmaceutical Group Co.,Ltd is currently in a long term uptrend where the price is trading 7.0% above its 200 day moving average.
From a valuation standpoint, the stock is 64.7% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 3.4.
Teyi Pharmaceutical Group Co.,Ltd's total revenue sank by 43.3% to $133M since the same quarter in the previous year.
Its net income has dropped by 96.3% to $1M since the same quarter in the previous year.
Finally, its free cash flow grew by 13.2% to $23M since the same quarter in the previous year.
Based on the above factors, Teyi Pharmaceutical Group Co.,Ltd gets an overall score of 3/5.